Form 4: Elevance Health CFO Sells Shares
Insider Transaction (Form 4)
Mark Kaye, EVP & CFO of Elevance Health, Inc., sold 10,584 shares of common stock on October 22, 2026.
Summary
- Open-market sale: disposed of 400 Common Stock at $434.00 ($173,600) on October 22, 2026; holds 30,103 after (Direct).
- Open-market sale: disposed of 321 Common Stock at $435.25 ($139,715) on October 22, 2026; holds 29,782 after (Direct).
- Open-market sale: disposed of 1,660 Common Stock at $436.20 ($724,092) on October 22, 2026; holds 28,122 after (Direct).
- Open-market sale: disposed of 560 Common Stock at $437.07 ($244,759) on October 22, 2026; holds 27,562 after (Direct).
- Open-market sale: disposed of 240 Common Stock at $438.22 ($105,173) on October 22, 2026; holds 27,322 after (Direct).
- Open-market sale: disposed of 1,160 Common Stock at $439.25 ($509,530) on October 22, 2026; holds 26,162 after (Direct).
- Open-market sale: disposed of 1,720 Common Stock at $440.44 ($757,557) on October 22, 2026; holds 24,442 after (Direct).
- Open-market sale: disposed of 2,343 Common Stock at $441.34 ($1,034,060) on October 22, 2026; holds 22,099 after (Direct).
- Open-market sale: disposed of 480 Common Stock at $442.61 ($212,453) on October 22, 2026; holds 21,619 after (Direct).
- Open-market sale: disposed of 440 Common Stock at $443.81 ($195,276) on October 22, 2026; holds 21,179 after (Direct).
- Open-market sale: disposed of 160 Common Stock at $444.85 ($71,176) on October 22, 2026; holds 21,019 after (Direct).
- Open-market sale: disposed of 827 Common Stock at $446.05 ($368,883) on October 22, 2026; holds 20,192 after (Direct).
- Open-market sale: disposed of 273 Common Stock at $447.19 ($122,083) on October 22, 2026; holds 19,919 after (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $4,658,357 of stock on the open market.
Insider Transactions
Mark Kaye — Officer (EVP & CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-22 | Open-market sale | Common Stock | 400 | $434 | $173.6K | 30,103 |
| 2026-10-22 | Open-market sale | Common Stock | 321 | $435 | $139.7K | 29,782 |
| 2026-10-22 | Open-market sale | Common Stock | 1,660 | $436 | $724.1K | 28,122 |
| 2026-10-22 | Open-market sale | Common Stock | 560 | $437 | $244.8K | 27,562 |
| 2026-10-22 | Open-market sale | Common Stock | 240 | $438 | $105.2K | 27,322 |
| 2026-10-22 | Open-market sale | Common Stock | 1,160 | $439 | $509.5K | 26,162 |
| 2026-10-22 | Open-market sale | Common Stock | 1,720 | $440 | $757.6K | 24,442 |
| 2026-10-22 | Open-market sale | Common Stock | 2,343 | $441 | $1.0M | 22,099 |
| 2026-10-22 | Open-market sale | Common Stock | 480 | $443 | $212.5K | 21,619 |
| 2026-10-22 | Open-market sale | Common Stock | 440 | $444 | $195.3K | 21,179 |
| 2026-10-22 | Open-market sale | Common Stock | 160 | $445 | $71.2K | 21,019 |
| 2026-10-22 | Open-market sale | Common Stock | 827 | $446 | $368.9K | 20,192 |
| 2026-10-22 | Open-market sale | Common Stock | 273 | $447 | $122.1K | 19,919 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-22 | Open-market sale (400 shares) |
| 2026-10-22 | Open-market sale (321 shares) |
| 2026-10-22 | Open-market sale (1,660 shares) |
| 2026-10-22 | Open-market sale (560 shares) |
| 2026-10-22 | Open-market sale (240 shares) |
| 2026-10-22 | Open-market sale (1,160 shares) |
| 2026-10-22 | Open-market sale (1,720 shares) |
| 2026-10-22 | Open-market sale (2,343 shares) |
| 2026-10-22 | Open-market sale (480 shares) |
| 2026-10-22 | Open-market sale (440 shares) |
| 2026-10-22 | Open-market sale (160 shares) |
| 2026-10-22 | Open-market sale (827 shares) |
| 2026-10-22 | Open-market sale (273 shares) |
Keywords
insider transaction, Form 4, ELV, Elevance Health, Inc., bearish, Mark Kaye
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.